合肥是中国显示产业的核心城市，也是全球非常重要的显示产业基地之一，形成了较为完善的新型显示 上下游产业生态。根据中国电子信息产业发展研究院发布的《中国新型显示产业高质量发展指数 (2025)》显示，2024—2025年中国显示产业高质量发展十大城市中，合肥位居首位。 国内领先的OLED面板厂商维信诺（002387）将迎来国资控股。11月9日晚，维信诺发布公告称，将向 公司股东合肥建曙投资有限公司(以下简称合肥建曙)定向增发4.19亿股，价格为每股7.01元，募集资金 总额不超过29.37亿元，扣除发行费用后拟全部用于补充流动资金及偿还公司债务。公告后的两个交易 日，维信诺公司股价收获2个涨停板。 合肥建曙是合肥国资背景的投资平台，此前已持有维信诺11.45%的股份。如若项目顺利完成，合肥建 曙将成为维信诺持股31.89%的控股股东，维信诺将从无实控人状态变更为国资股东控股，有望从战略 规划、经营管理、资源整合、市场信心等多维度释放更多长期价值。 国资赋能OLED产业发展 合肥建曙2021年入股维信诺，本次定增全额认购是其又一次参与的资本项目，是对维信诺未来前景和价 值的持续认可，也是其对OLED产业发展的支持 ...

本雪季，发展目标是接待冰雪游客突破1.8亿人次，游客出游总花费达3300亿元以上，两项指标均实现 两位数增长。 11月12日，在2025-2026新雪季系列新闻发布会(第三场)上，吉林省文旅厅厅长孙光芝表示，省级层面将 安排冰雪消费券1亿元，通过青少年上冰雪、引客入吉、冰雪直通车、线上满减消费券等方式，精准撬 动滑雪、景区、演唱会、交通等冰雪消费场景。 叠加各地出台的促消费政策，本雪季惠民力度空前。例如长春市推出7500万元的冰雪商贸消费券；吉林 市给予外地游客餐饮专属优惠，重要节假日免费乘公交、城区免费停车；通化市定向推出"疗休养"团队 免费学滑雪政策；松原市推出"一张票根游松原""冬捕免费直通车"政策；延边州给予"引客入延"旅行社 补贴；长白山（603099）出台"0元联游"北、西景区，东北三省高校大学生免门票等政策。 本雪季，发展目标是接待冰雪游客突破1.8亿人次，游客出游总花费达3300亿元以上，两项指标均实现 两位数增长。 ...

Core Viewpoint - Mindray Medical (300760), a leading domestic medical device company, has submitted its application for a Hong Kong IPO, aiming for a dual listing in both A-share and H-share markets, with joint sponsors being Huatai International and JPMorgan [1] Group 1: IPO and Fundraising - The IPO will combine public offerings in Hong Kong with international placements, with the specific issuance scale to be determined based on market conditions [1] - The funds raised will primarily be used to enhance global R&D investment, innovate products and digital solutions, explore potential global mergers and collaborations, and improve global sales networks and supply chain capabilities [1] Group 2: Business Performance and Market Position - Mindray Medical is the only Chinese company among the top 30 global medical device firms, with a comprehensive product line that includes monitoring devices, anesthesia systems, ventilators, defibrillators, blood cell analyzers, and ultrasound equipment, all ranking in the top three globally [1] - The company is projected to achieve a revenue of 36.7 billion yuan in 2024, with a compound annual growth rate (CAGR) of over 18% from 2017 to 2024, and a net profit CAGR exceeding 24% [2] Group 3: Competitive Advantages - In the in-vitro diagnostics sector, Mindray is the largest provider in China and the second largest globally for blood cell diagnostics, as well as the largest domestic provider of chemical luminescence immunoassays [3] - The company holds significant market shares in various categories, including being the largest provider of monitoring devices in China and the second largest globally [3] Group 4: R&D and Innovation - Mindray has invested approximately 12.8 billion yuan in R&D, employing 5,200 specialized R&D personnel across 12 global centers, and has filed over 12,240 patents [4] - The company emphasizes its commitment to independent innovation, continuously increasing R&D investment to meet international standards [4] Group 5: Strategic Directions - Mindray is transitioning towards a sustainable growth model centered on recurring revenue from consumables and digital services, while maintaining its leadership in equipment sales [5] - The company plans to enhance its presence in minimally invasive surgery and intervention fields, aiming to shift from one-time equipment sales to a sustainable, repeat-purchase revenue model [5] Group 6: Future Growth and Market Expansion - By the first half of 2025, recurring revenue from consumables is expected to account for about 40% of total revenue, with significant growth potential in the domestic market [6] - The IPO is seen as a strategic move to bolster investments in digitalization, recurring revenue, and internationalization, which are critical for future growth [6]

Core Insights - The company is focusing on traditional advantageous markets such as Sichuan, Hebei, Shandong, and Northeast China, while continuing to promote national brand expansion [1] - The company is enhancing its market penetration through channel downscaling and C-end operations, aiming to create "small regions with high market share" [1] - E-commerce sales have seen a significant increase, with a year-on-year growth of 39.62% in the first three quarters [1] Group 1 - The company reported a 16.46% year-on-year increase in ordinary liquor sales revenue, reaching 625 million yuan, driven by the strong performance of its strategic flagship product, T68 [1] - The company is actively exploring new consumption scenarios and expanding its consumer base through innovative marketing strategies, including online launches and offline promotional events [2] - The company is leveraging emerging channels such as live streaming and instant retail to enhance its e-commerce sales proportion [1] Group 2 - The new product "Shide Zizai" is primarily launched through online channels, utilizing traditional fast-moving consumer goods marketing strategies to quickly validate target demographics and pricing [2] - The product is positioned to cater to various social consumption scenarios, including casual gatherings and home consumption, reflecting a focus on emotional and relaxed social experiences [2]

另外，新车还配备了"二代短刀电池"、长城宝马团队打造的"底盘调校"，以及CLTC工况11.6kWh/100km的极低能耗。 11月12日，长城汽车欧拉品牌宣布旗下全新A级纯电SUV欧拉5正式开启预售，共推出五款车型，预售价区间为10.98万–14.28万。 设计方面，欧拉5采用"自然美学"设计，更是搭载了"极光绿"液态金属漆。而在年轻用户普遍关注的智能化方面，欧拉5搭载长城汽车全栈自研的Coffee Pilot Ultra辅助驾驶系统，配备激光雷达等27个感知硬件，实现了不依赖高精地图的全场景NOA，同时支持跨楼层记忆泊车等200多种泊车场景。 作者 | 贾子健 编辑 | 安安 欧拉还介绍称，此次欧拉品牌与侯明昊"牵手"成功，源于双方精神内核的高度契合。侯明昊"年轻、阳光、活力"的个人形象 ，正是当代年轻人"活出光芒"精 神的具象呈现，也是欧拉品牌精神的完美诠释。 官方资料显示，欧拉品牌已走进全球50多个国家和地区，赢得近60万用户的信赖。作为长城汽车首款纯电SUV，欧拉5的预售发布，不仅标志着欧拉品牌焕 新的关键一步，更清晰地释放全球产品战略的雄心。 ...

Core Viewpoint - The launch of the SAIC flagship six-seater vehicle, the Zhiji LS9, introduces two super range-extended versions, showcasing advanced technology and features aimed at meeting consumer expectations for a premium electric vehicle [1][3]. Group 1: Product Features - The Zhiji LS9 is available in two versions: the 52 Ultra priced at 322,800 yuan and the 66 Ultra with a 66 kWh battery priced at 352,800 yuan [1]. - It features the Lingxi Digital Chassis 3.0, a dual-direction 24° smart four-wheel steering system, and a small turning radius of only 4.95 meters [1]. - The vehicle is equipped with a 150mm large stroke dual-chamber closed smart air suspension and an intelligent electronic damping adjustment system [1]. Group 2: Performance and Range - The Zhiji LS9 boasts a dual-motor vector four-wheel drive system with a maximum output of 390 kW and 670 N·m of torque, achieving 0-100 km/h acceleration in 4 seconds [3]. - It offers a maximum pure electric range of 402 km (CLTC) and a comprehensive range of 1508 km, with a fuel consumption equivalent of 2.81 L/100 km [3]. Group 3: Advanced Technology - The vehicle includes the industry's first "Comfort Anti-Nausea Mode" based on full-domain collaborative control and is equipped with 800V architecture [3]. - It features 520-line ultra-vision lidar and the NVIDIA Thor chip, along with the IM AD Max driver assistance system co-developed with Momenta [3]. - The Zhiji LS9 introduces AI Agent for various services such as parking payment and food ordering, enhancing the smart cabin experience [3]. Group 4: Comfort and Luxury - The vehicle is designed with three zero-gravity seats, a luxury B&O sound system, 4D mechanical massage seats, and innovative air purification and intelligent heating systems [3]. - The introduction of the ERNC 2.0 active noise reduction technology ensures a seamless experience when the range extender is engaged [3].

11月11日，胖东来商贸集团发布许昌胖东来招聘公告，披露招聘2名中英翻译助理。招聘目的即为国际专家做助理翻 译，有效促进思想交流与沟通，以及通过精准翻译，学习和分享世界先进文化，促进企业人文发展和人们幸福度的提 升。 任职资格指出，该职位教育背景要求第一学历毕业于QS排名前50院校，主修翻译学、英语、国际交流或相关专业；有 海外留学或工作经历者；有心理学/哲学/法律/历史专业或有丰富商业背景从业者优先。性别和年龄要求则为40周岁及 以下女性。 薪资待遇方面，该职位可享有带薪休假不低于60天，具体面谈；且年薪不低于50万，根据实际能力可面谈。 （企业公众号） ...

11月10日，英矽智能在其微信公众号宣布，与跨国药企礼来（Lilly）达成药物研发战略合作。双方将充分发挥英矽智 能自主研发的AI制药平台Pharma.AI的前沿技术优势，结合礼来在药物开发及疾病研究领域的深厚积淀，共同加速创新 疗法的发现与开发。 根据协议，英矽智能将依托已广泛验证的Pharma.AI平台及专业药物研发能力，就双方确定的创新靶点开展候选化合物 的生成、设计与优化。英矽智能有权从该项合作中获得最高逾1亿美元（约合人民币7.12亿元）的收益，包括首付款、 研发里程碑付款以及未来药品商业化后的分级净销售额版税。 此次合作标志着双方伙伴关系的进一步升级。早在2023年，英矽智能与礼来已基于AI平台达成软件授权合作，为本次 战略合作打下坚实基础。 （英矽智能微信公众号） ...

Core Insights - Li Ning publicly unveiled its Super Capsule Technology at the 14th National Sports Science Conference, marking a significant breakthrough for its 2024 technology platform [1] - The technology utilizes advanced materials and a unique supramolecular polymer outer layer to create a capsule system that achieves energy storage and rapid rebound through a dual airbag effect [1] - Third-party tests indicate that the midsole material has a density of 0.1g/cm³, an energy return rate of 95%, and a rebound response time of 3 milliseconds, with only a 0.6% deformation rate after 100,000 fatigue tests, equivalent to five marathons [1] Technology Development - Li Ning has established a "Technology R&D + Sports Science Research" dual-engine technology platform, with its Sports Science Research Center founded in 2008 [1] - The center has developed a youth sports database and an Asian foot shape database with thousands of samples, collaborating with over 30 universities and research institutions, resulting in over 130 papers and 549 patents [1] - The Super Capsule Technology continues the path of technology platformization initiated in 2019, with the current platform comprising four major branches, covering over 60% of the company's footwear products [1] Strategic Focus - The General Manager of Li Ning's Footwear R&D Innovation System, Xu Jian Guang, emphasized that research and innovation are key driving forces for brand development and upgrades [1]

#晶澳科技发公告#【晶澳科技：公司董事会秘书未在任何内部或外部会议上发表过网传言论】#晶澳科 技公告董事会秘书未发表过网传言论#晶澳科技11月12日晚间公告，近日，网络上流传关于晶澳太阳能 科技股份有限公司的不实言论，引发部分关注。对此，公司澄清并郑重声明如下：公司董事会秘书未在 任何内部或外部会议上发表过网传言论。相关内容系网络谣传，严重误导公众认知，损害公司及行业声 誉。针对不实言论的传播行为，公司保留通过法律途径追究相关责任的权利。公司提醒广大投资者、合 作伙伴及社会公众，应通过证监会指定信息披露媒体、公司官方渠道了解真实信息，不信谣、不传谣， 共同维护健康的市场秩序与舆论环境。（界面） ...